MedTrace Logo

ICP Versus Intracranial Compliance Guided Management in SAH

NCT00248690 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2011-01-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether treatment guided also by ICP mean wave amplitude improves outcome compared to international standard care in patients with SAH.

Conditions

  • Subarachnoid Hemorrhage (SAH)

Interventions

DEVICE

ICP mean wave amplitude

Appropriate measures when ICP mean wave amplitude is to high, e.g. CSF drainage

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Gunnar Bentsen, MD · Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2009-02-28
Completion
2009-06-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00248690 on ClinicalTrials.gov